Ann Chen
17Patents
1h-index
26Co-inventors
50Inventor score
Filing activity: Jun 17, 2009 → Oct 29, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9844560B2 | Use of ginsenoside M1 for treating lupus nephritis | Human Necessities | 3 | Active |
| US10172876B2 | Use of ginsenoside M1 for treating IgA nephropathy | Human Necessities | 1 | Active |
| US8178358B2 | Serpine2 as a biomarker for IgA nephropathy | Physics | 0 | Active |
| US8329410B2 | Method for diagnosing kidney disease comprising detecting the level of annexin A2 | Physics | 0 | Active |
| US9475789B2 | Use of polyenylpyrrole derivatives for treating inflammation | Human Necessities | 0 | Active |
| US9295705B2 | Treatment for nephritis | Human Necessities | 0 | Active |
| US12090132B2 | Tris DBA pharmaceutical composition and its use for treating autoimmune diseases | Human Necessities | 0 | Active |
| US9393226B2 | Use of osthole for treating focal segmental glomerulosclerosis | Human Necessities | 0 | Active |
| US8414938B2 | Schisandrae fructus extracts for inhibition or prevention of H1N1 influenza virus infection and its application thereof | Human Necessities | 0 | Active |
| US8993637B2 | Use of citral for treating focal segmental glomerulosclerosis | Human Necessities | 0 | Active |
| US8785137B2 | Method for renal disease diagnosis using Rab23 as marker | Chemistry; Metallurgy | 0 | Active |
| US8518461B2 | Use of bamboo vinegar for treating inflammation | Human Necessities | 0 | Active |
| US9321795B2 | Use of hydroxycinnamaldehyde glycoside derivatives for treating glomerulonephritis | Human Necessities | 0 | Active |
| US8329651B2 | Method for renal disease diagnosis and prognosis using annexin A1 and Rab23 as markers | Chemistry; Metallurgy | 0 | Active |
| US11834647B2 | In vitro immune synapse system and method of in vitro evaluating immune response using the same | Physics | 0 | Active |
| US12000841B2 | Diagnostic kits and methods configured to rapidly and non-invasively determine physiologic levels of galactose-deficient IgA1 (Gd-IgA1) in the subject of IgA nephropathy | Physics | 0 | Active |
| US10357507B2 | Use of ginsenoside M1 for inhibiting renal fibrosis | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.